Alerts will be sent to your verified email
Verify Email
AAREYDRUGS
|
Aarey Drugs & Pharma
|
Tyche Inds
|
Bal Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.07 % | 14.86 % | 1.96 % |
|
5yr average Equity Multiplier
|
2.28 | 1.18 | 4.59 |
|
5yr Average Asset Turnover Ratio
|
1.56 | 0.6 | 0.98 |
|
5yr Avg Net Profit Margin
|
1.44 % | 20.15 % | -0.04 % |
|
Price to Book
|
1.14 | 1.16 | 2.25 |
|
P/E
|
26.92 | 11.4 | 21.31 |
|
5yr Avg Cash Conversion Cycle
|
77.34 Days | 86.71 Days | 41.77 Days |
|
Inventory Days
|
20.31 Days | 61.45 Days | 106.16 Days |
|
Days Receivable
|
172.65 Days | 108.17 Days | 104.16 Days |
|
Days Payable
|
98.9 Days | 93.08 Days | 132.37 Days |
|
5yr Average Interest Coverage Ratio
|
4.14 | 2385.83 | 1.22 |
|
5yr Avg ROCE
|
8.93 % | 19.65 % | 15.4 % |
|
5yr Avg Operating Profit Margin
|
1.54 % | 23.57 % | 7.79 % |
|
5 yr average Debt to Equity
|
0.21 | 0.0 | 2.03 |
|
5yr CAGR Net Profit
|
-4.17 % | -6.96 % | n/a |
|
5yr Average Return on Assets
|
2.26 % | 12.43 % | 0.43 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
44.8 % | 61.97 % | 50.86 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-3.26 % | 0.0 | 1.29 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Aarey Drugs & Pharma
|
Tyche Inds
|
Bal Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|